MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
54.42
-0.46 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
54.39
-0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
MoonLake Immunotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 306.68M | 271.57M | 180.43M | 375.66M | 342.79M | 458.44M | 451.17M | 318.17M | 501.79M | 50.13M | 39.51M | 41.2M | 92.71M | 101.02M | 8.04M | 1.03M | 1.1M | 1.17M |
Short-Term Investments | 118.4M | 208.56M | 267.6M | 118.27M | 177.01M | 88.61M | 59.84M | 177.81M | n/a | 12.92M | 32.61M | 42.25M | n/a | n/a | n/a | n/a | n/a | 115.01M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 115.05M | 115.04M | 115.04M | 115.04M | 115.03M |
Other Long-Term Assets | 1.7M | 1.7M | n/a | 2.06M | 4.13M | 6.32M | 8.42M | n/a | n/a | 0.00 | n/a | n/a | n/a | -59.26K | -115.04M | -29.85K | n/a | n/a |
Receivables | 3.41M | 2.99M | 2.84M | 2.41M | 1.68M | 1.5M | 1.06M | 720.75K | 619.77K | 378.44K | 217.13K | 600.54K | 557.05K | 15M | 148.77K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 455.48M | 506.26M | 474.29M | 512.32M | 536.88M | 553.59M | 514.17M | 500.01M | 506.37M | 66.5M | 76.51M | 88.54M | 98.38M | 116.16M | 9.64M | 1.21M | 1.33M | 1.46M |
Property-Plant & Equipment | 2.92M | 3.3M | 3.64M | 3.83M | 3.87M | 4.21M | 3.95M | 208.94K | 254.05K | 292.36K | 331.97K | 52.68K | 55.97K | 59.26K | 45.74K | 29.85K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.62M | 5M | 3.64M | 5.9M | 8M | 10.53M | 12.37M | 208.94K | 254.05K | 292.36K | 331.97K | 52.68K | 55.97K | 115.05M | 45.74K | 115.04M | 115.04M | 115.03M |
Total Assets | 460.1M | 511.26M | 477.93M | 518.21M | 544.88M | 564.12M | 526.54M | 500.22M | 506.62M | 66.8M | 76.84M | 88.59M | 98.43M | 231.21M | 9.68M | 116.25M | 116.37M | 116.49M |
Account Payables | 14.89M | 14K | 8.68M | 104.32K | 55.98K | 1.63M | 553.46K | 824.07K | 270.75K | 510.52K | 65.98K | 155.53K | 246.75K | 213.45K | 1.23M | 95.66K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -185.48K | n/a | -270.75K | n/a | n/a | n/a | n/a | -213.45K | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.55M | 1.43M | 1.37M | 1.44M | n/a | n/a | n/a | n/a | 158.22K | 155.17K | n/a | n/a | n/a | 15.15M | 15M | n/a | n/a | n/a |
Other Current Liabilities | 21.74M | 21.1M | -10.14M | 1.48M | 7.5M | 1.05M | 259.73K | 2.76M | 745.86K | 4.23M | 1.11M | 217.14K | 1.81M | 182.57M | 1.3M | -1.54M | 90K | 60K |
Total Current Liabilities | 27.36M | 23.98M | 22.46M | 20.08M | 12.28M | 8.91M | 9.97M | 10.31M | 7.13M | 7.28M | 7.67M | 6.02M | 3.86M | 202.79M | 21.09M | 2.06M | 90K | 60K |
Long-Term Debt | 73.38M | 74.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 574K | 536K | 620.68K | 694.96K | 541.95K | 462.74K | 583.42K | 255.4K | 323.6K | 314.17K | 282.21K | 4.99K | 18.59K | 4.03M | 239.86K | 4.03M | 4.03M | 4.03M |
Total Long-Term Liabilities | 74.79M | 74.7M | 2.08M | 2.63M | 2.56M | 2.82M | 3.08M | 268.48K | 376.61K | 405.25K | 411.16K | 4.99K | 18.59K | 4.03M | 239.86K | 4.03M | 4.03M | 4.03M |
Total Liabilities | 102.15M | 98.68M | 24.54M | 22.71M | 14.85M | 11.73M | 13.05M | 10.58M | 7.51M | 7.68M | 8.08M | 6.02M | 3.88M | 206.82M | 21.33M | 6.08M | 4.12M | 4.08M |
Total Debt | 75.77M | 75.6M | 2.83M | 3.69M | 3.34M | 3.66M | 3.7M | 169.42K | 211.24K | 246.25K | 282.58K | n/a | n/a | 15.15M | 15M | n/a | n/a | n/a |
Common Stock | 6K | 6K | 6.39K | 6.39K | 6.39K | 6.39K | 6.3K | 6.25K | 6.25K | 5.27K | 5.27K | 5.27K | 5.27K | 673.00 | 38.54K | 115M | 107.26M | 107.41M |
Retained Earnings | -330.76M | -275.54M | -235.59M | -189.99M | -154.6M | -130.33M | -116.66M | -109.22M | -99.79M | -89.66M | -80.65M | -68.79M | -58.68M | -9.76M | -53.64M | -4.84M | -319.46K | -167.13K |
Comprehensive Income | 520K | 2.39M | 5M | 2.83M | 3.26M | 2.69M | 2.36M | 2.88M | 35.12K | 340.11K | 350.95K | 245.28K | 133.72K | 98.09K | -168.18K | 0.00 | n/a | n/a |
Shareholders Equity | 353.73M | 407.52M | 446.82M | 488.2M | 520.66M | 542.55M | 495.68M | 424.93M | 489.8M | 42M | 48.9M | 55.29M | 63.51M | 24.4M | -11.65M | 110.16M | 112.26M | 112.41M |
Total Investments | 118.4M | 208.56M | 267.6M | 118.27M | 177.01M | 88.61M | 59.84M | 177.81M | n/a | 12.92M | 32.61M | 42.25M | n/a | 115.05M | 115.04M | 115.04M | 115.04M | 115.03M |